Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Anesthesiology. 2013 Aug;119(2):10.1097/ALN.0b013e3182987af4. doi: 10.1097/ALN.0b013e3182987af4

Table 3.

Demographics and Comorbidities between intervention and control groups.

Intervention n = 47 Control n = 47

Age 63 (53.5, 67.5) 57 (45.5, 64.5)
Predicted Body Weight 63.9 (57.0, 71.9) 68.4 (55.3, 74.2)
ASA Status 4 (3, 4) 4 (3, 4)
Preoperative P/F Ratio 201 (176.1, 230.9) 184.8 (140.2, 221.3)
Male 29 62% 30 64%
Emergent Surgery 15 32% 18 38%
Hypertension 27 57% 25 53%
CAD 20 43% 15 32%
CHF 8 17% 16 34%
Pneumonia 7 15% 6 13%
COPD 11 23% 9 19%
Asthma 2 4% 2 4%
OSA 10 21% 10 21%
Hepatic Disease 6 13% 12 26%
Renal Failure 16 34% 17 36%
Diabetes 15 32% 14 30%
Bilateral Infiltrates on CXR 36 72% 31 62%

There were no statistically significant differences between groups in any parameter. Values are represented as median (IQR) or n (%). ASA = American Society of Anesthesiologists, CAD = coronary artery disease, CHF = congestive heart failure, COPD = chronic obstructive pulmonary disease, CXR = chest x-ray, P/F = ratio of partial pressure of arterial oxygen to inspired fraction of oxygen, OSA = obstructive sleep apnea.